Navigation Links
Mass. General researchers develop functional, transplantable rat liver grafts
Date:6/13/2010

A team led by researchers from the Center for Engineering in Medicine at Massachusetts General Hospital (MGH) has developed a technique that someday may allow growth of transplantable replacement livers. In their report that will be published in Nature Medicine and is receiving early online release, the investigators describe using the structural tissue of rat livers as scaffolding for the growth of tissue regenerated from liver cells introduced through a novel reseeding process.

"Having the detailed microvasculature of the liver within a biocompatible, natural scaffold is a major advantage to growing liver tissue in a synthetic environment," says Basak Uygun, PhD, research associate at the MGH Center for Engineering in Medicine (MGH-CEM) and the paper's lead author. "Our technique of 'decellularizing' organs leaves the vascular system intact, which facilitates repopulation of the structural matrix and the subsequent survival and function of the introduced liver cells."

Liver transplantation is the only effective treatment for liver failure but is greatly limited by the shortage of donor organs. Each year 4,000 individuals who might have survived with a liver transplant die in the U.S. The shortage of donor livers and other organs is a major force behind the emerging field of tissue engineering and regenerative medicine. Efforts to build tissues from the ground up have not yet approached the goal of transplantable replacement organs, and replacing the liver in which each cell is a metabolic factory requiring constant, direct contact with the vascular system has been particularly challenging.

The current report describes a refinement of an approach to re-engineering replacement rat hearts that was reported in 2008 by University of Minnesota researchers. Since liver tissue is much more delicate than the muscular structure of the heart, the MGH-CEM team developed a gentler way of flushing living cells out of the liver's
'/>"/>

Contact: Sue McGreevey
smcgreevey@partners.org
617-724-2764
Massachusetts General Hospital
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Mass. Generals Warren Triennial Prize honors discoverers of microRNAs
2. Mass. General study shows how exercise changes structure and function of heart
3. Oil Refineries Announces Delay to Annual & Special General Meeting
4. American Society for Microbiology to host 110th general meeting in San Diego
5. Modern man found to be generally monogamous, moderately polygamous
6. HFSP President Arima and Secretary General Winnacker awarded for fostering cooperation with China
7. TWAS 11th General Conference
8. General tumor marker test now offered by GenWay clinical laboratory
9. American Society for Microbiology to host 109th general meeting in Philadelphia
10. Journal of General Physiology explores mysteries of TRP channels in latest Perspectives series
11. March of Dimes announces Prematurity Campaign expansion at Surgeon Generals conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/9/2015)... JOSE, Calif. , April 9, 2015 ... human interface solutions, announced today that it will report ... on Thursday, April 23, 2015, after the close of ... for analysts and investors at 2:00 p.m. PT (5:00 ...   To participate on the live call, ...
(Date:4/2/2015)... In the current eight ... the strongest competitors, showing outstanding performance in recognition ... is capable of a throughput of 5.000.000 fingerprints ... be ten times faster than most competitors and ...      (Photo: http://photos.prnewswire.com/prnh/20150402/738673-a ) , ...
(Date:4/2/2015)... GOTHENBURG, Sweden , April 2, 2015 ... for its touch fingerprint sensor FPC1025 from the distributor ... Deliveries will commence during Q2 2015 although the major ... 2015. The sensors will be used by smartphone manufacturers ... of 110 MSEK is included in the communicated revenue ...
Breaking Biology News(10 mins):Synaptics to Report Third Quarter Results on April 23 2DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 2DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 3Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 110 Million 2
... German . , Berlin, 2 September 2009 - ... ecosystems - from forests and mangroves to wetlands and river ... change and climate-proofing vulnerable economies. This is among the ... Economics of Ecosystems and Biodiversity (TEEB), a project launched by ...
... JACKSONVILLE, Fla. In a biological rendition of fiction,s ... the Mayo Clinic campus in Florida and Harvard Medical School ... development can actually spur the spread of tumors. ... Molecular and Cellular Biology , found that FOXO3a, a transcription ...
... that comes to mind when people think of Alzheimer,s disease, ... and France, this might change. That,s because these researchers have ... might be the key that unlocks an entirely new class ... report published online in The FASEB Journal ( ...
Cached Biology News:Time to tap climate change-combating potential of the world's ecosystems 2Time to tap climate change-combating potential of the world's ecosystems 3Time to tap climate change-combating potential of the world's ecosystems 4Time to tap climate change-combating potential of the world's ecosystems 5Mayo Clinic researchers find that protein believed to protect against cancer has a Mr. Hyde side 2Scientists begin to untangle root cause of Alzheimer's disease 2
(Date:5/6/2015)... 6, 2015  Endo International plc (NASDAQ: ENDP ) ... President and CEO, will present a corporate overview at the ... on Wednesday, May 20, 2015 at 11:00 a.m. ... for the event will be available on the Company,s website ... the link to the event. Participants should allow approximately 10 ...
(Date:5/6/2015)... -- Northwest Biotherapeutics (NASDAQ: NWBO) ("NW Bio"), a U.S. biotechnology company ... announced that Linda Powers , NW Bio CEO, will present ... for solid tumor cancers and the Company,s multiple clinical programs ... , , , DATE: , , , Thursday, May ... , 12:15 PM EDT , , , , LINK: ...
(Date:5/6/2015)... Histogen, Inc., a regenerative medicine company ... grown under simulated embryonic conditions, will present new ... melanoma during the 2015 Society of Investigative Dermatology ... in Atlanta, GA. , Histogen has previously shown ... with anti-oncologic properties, with potential benefit in the ...
(Date:5/5/2015)... May 5, 2015  Blueprint Medicines (NASDAQ: ... initial public offering of 9,367,708 shares of common ... per share, including shares of common stock issued ... their option to purchase additional shares. The gross ... Medicines were approximately $168.6 million, before underwriting discounts and ...
Breaking Biology Technology:NW Bio To Webcast, Live, at VirtualInvestorConferences.com On May 7 2NW Bio To Webcast, Live, at VirtualInvestorConferences.com On May 7 3Novel Immunomodulatory Treatment Induces Apoptosis in Melanoma 2Blueprint Medicines Announces Closing of Initial Public Offering 2
... Vermillion, Inc. (NASDAQ: VRML ), a molecular ... Trademark Office (USPTO) has issued a notice of allowance for ... claims cover the biomarker alpha1beta glycoprotein and biomarker combinations that ... "This will be our third patent for biomarkers that ...
... in hospitals is increasing. Bacteria acquire resistance to antibiotics ... genes, either from the surrounding environment or from other ... research (University of Lisbon) and the Instituto Gulbenkian de ... resistance are playing out in the bacterium Escherichia ...
... signals, for the first time, to assist in braking, ... to the thousands of car accidents that are caused ... technique that attaches electrodes to the scalp , the ... traffic sensors, could detect a driver,s intention to break ...
Cached Biology Technology:Vermillion Announces Notice of Allowance for Peripheral Artery Disease (PAD) Patent 2Vermillion Announces Notice of Allowance for Peripheral Artery Disease (PAD) Patent 3Bacterial resistance to antibiotics: The more they resist, the more they divide 2Put the brakes on using your brain power 2
Rabbit polyclonal to Tryptophanyl tRNA synthetase ( Abpromise for all tested applications). Antigen: Recombinant full length protein (Human): Tryptophanyl tRNA synthetase Entrez Gene ID: 745...
Goat polyclonal to FBXO2 ( Abpromise for all tested applications). entrezGeneID: 26232 SwissProtID: Q9UK22...
Rat monoclonal to UGGT ( Abpromise for all tested applications)....
... anti-phospho-FAK (Ser843) Immunogen: ... region encompassing the human, mouse, and ... Accession Number: NM_153831 ... evaluated by immunoblot. ...
Biology Products: